12:00 AM
 | 
Sep 29, 2014
 |  BC Week In Review  |  Company News  |  Other News

Silarus Therapeutics Inc., Thyritope Biosciences Inc., GlaxoSmithKline hematology, endocrine/metabolic, autoimmune news

Avalon Ventures and GlaxoSmithKline launched Silarus and Thyritope. Each company may receive up to $10 million in series A financing, comprising $3 million in equity investment from Avalon and up to $7 million in R&D support from GSK. The companies will be housed at Avalon's COI Pharmaceuticals incubator and funded on a quarterly basis....

Read the full 246 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >